<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190315043058N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-03-29</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of sciatic nerve mobilization on pain, functional disability, sciatic nerve morphology and lower extremity muscles morphology in patients with lumbar radiculopathy due to disc herniation: A randomized controlled trial.</public_title>
      <acronym></acronym>
      <scientific_title>The effect of sciatic nerve mobilization on pain, functional disability, sciatic nerve morphology and lower extremity muscles morphology in patients with lumbar radiculopathy due to disc herniation: A randomized controlled trial.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-04-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>46</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/76115</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: After completion of personal information and initial evaluations, patients with low back pain with radiculopathy symptoms will be randomly divided into two groups A or main treatment group: group B and control group receiving nerve mobilization placebo technique. Random allocation will be done in the variable block method, which consists of four-letter blocks made up of letters A and B. Then, the random list of treatments that will be obtained at the end of the assignment will be placed in the letters A and B in sealed and numbered envelopes (letter A represents nerve mobilization technique and the letter B represents the placebo technique of nerve mobilization). The random assignment process will be performed by an outside of the research team before the start of the study. After the initial evaluation by the examiner, the numbered envelopes will be presented to each person entering the study. Finally, after the patient enters the therapy sessions, the therapist will adjust the treatment interventions based on the letters in the envelope, Blinding description: Participants will be given envelopes in a closed envelope before the start of the first treatment session, and one of the letters A or B is written. Attendees deliver envelopes to their therapist, only the therapist is allowed to open the envelopes.
The evaluator does not know the groups of participants.</study_design>
      <phase>N/A</phase>
      <hc_freetext>patients with lumbar radiculopathy due to disc herniation.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Mobilization of the sciatica nerve (gliding). Intervention 2: Intervention group: Electrotherapy will consist of 20 minutes of conventional TENS (parameters include frequency 80-100 Hz; pulse width 50-100 microseconds; Flow Mode: Continuous; Patient Sense: Tingling within the patient's tolerance range). Intervention 3: Control group: Shame sciatic nerve mobilization techniques (nerve gliding). Intervention 4: Control group: Electrotherapy will consist of 20 minutes of conventional TENS (parameters include frequency 80-100 Hz; pulse width 50-100 microseconds; Flow Mode: Continuous; Patient Sense: Tingling within the patient's tolerance range).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Esmaeel Ebrahimi Takamjani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahnazari Ave., Mirdamad Blvd., Tehran Town</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1998135353</zip>
        <telephone>+98 21 2239 2426</telephone>
        <email>ebrahimitakamjani.e@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Maryam Ahmadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahnazari Ave., Mirdamad Blvd., Tehran Town</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1998135353</zip>
        <telephone>+98 21 2239 2426</telephone>
        <email>maryamahmadima226@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>46 patients with radiculopathy in one leg for at least 3 months (having at least one of the symptoms: pain, numbness, tingling)
Age between 18-55
Positive SLR test at an angle of 20 to 70 degrees
Pain score based on the NPRS scale in the lower back should be more than 40 and less than 60 during the last 24 hours at rest.
BMI&lt;30
Confirmation of disc bluging using MRI at levels of L4-L5 and L5-S1.
Having a minimum reading and writing literacy (cycle) to fill out questionnaires.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>55 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Absence of any underlying disease, including diabetes, previous problems, etc.
Any dissatisfaction and lack of participation of patients during the course of treatment.
Low back pain due to rheumatoid arthritis, inflammation of the spine joints, infection, spondylolisthesis, fracture, trauma, osteoporosis, etc.
pregnancy
Physical therapy at least 1 month ago
Any disease during the course of treatment that interferes with the research process.
Injury to the limbs or back area during the course of treatment.
Absence of more than 2 sessions during the course of treatment.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Placebo</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Mobilization of the sciatica nerve (gliding)</i_keyword>
      <i_keyword>Intervention group: Electrotherapy will consist of 20 minutes of conventional TENS (parameters include frequency 80-100 Hz; pulse width 50-100 microseconds; Flow Mode: Continuous; Patient Sense: Tingling within the patient's tolerance range).</i_keyword>
      <i_keyword>Control group: Shame sciatic nerve mobilization techniques (nerve gliding)</i_keyword>
      <i_keyword>Control group: Electrotherapy will consist of 20 minutes of conventional TENS (parameters include frequency 80-100 Hz; pulse width 50-100 microseconds; Flow Mode: Continuous; Patient Sense: Tingling within the patient's tolerance range).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: Measurement of pain is done at the beginning of the study (before the intervention) and the last treatment period. Method of measurement: Numeric pain rating scale (Moderate back pain in the last 24 hours at rest).</prim_outcome>
      <prim_outcome>Functional disability. Timepoint: Measurement of pain is done at the beginning of the study (before the intervention) and the last treatment period. Method of measurement: Persian version of Oswestery disability index.</prim_outcome>
      <prim_outcome>Straight  leg raise Angle. Timepoint: Measurement of pain is done at the beginning of the study (before the intervention) and the last treatment period. Method of measurement: Goniometer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Changes in Sciatic Nerve Morphology. Timepoint: At the beginning of the study (before the intervention) and immediately after the last treatment session. Method of measurement: Ultrasonography devices.</sec_outcome>
      <sec_outcome>Morphological Changes in Lower Extremity Muscles. Timepoint: At the beginning of the study (before the intervention) and immediately after the last treatment session. Method of measurement: Ultrasonography devices.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-03-11</approval_date>
        <contact_name>Ethics committee of Iran university of medical sciences</contact_name>
        <contact_address>Hemmat Highway.,  next to Milad Tower Iran University of Medical Sciences Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
